(Q35116375)

6 August 2017

title

Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic (English)

1 reference

6 August 2017

Goldstein BP

1

1 reference

6 August 2017

Candiani G

2

1 reference

6 August 2017

Arain TM

3

1 reference

6 August 2017

Romanò G

4

1 reference

6 August 2017

Ciciliato I

5

1 reference

6 August 2017

Berti M

6

1 reference

6 August 2017

Abbondi M

7

1 reference

6 August 2017

Scotti R

8

1 reference

6 August 2017

Mainini M

9

1 reference

6 August 2017

Ripamonti F

10

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

39

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

1580-1588

1 reference

Characterization of glycopeptide-resistant enterococci from U.S. hospitals

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

In vitro activity of the semisynthetic glycopeptide amide MDL 63,246

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Emergence of vancomycin resistance in coagulase-negative staphylococci

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

A40926 aglycone and pseudoaglycones: preparation and biological activity.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

A40926, a new glycopeptide antibiotic with anti-Neisseria activity

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

High-level vancomycin-resistant enterococci causing hospital infections

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

The life and times of the Enterococcus

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Ramoplanin versus methicillin-resistant Staphylococcus aureus: in vitro experience.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Two distinct forms of vancomycin resistance amongst enterococci in the UK.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococi, enterococci and Clostridium difficile

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162785

Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium

9 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7492108

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of protein on ramoplanin broth microdilution minimum inhibitory concentrations.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7492108

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.39.7.1580

1 reference

6 August 2017

1 reference

6 August 2017

1 reference